Depressive symptoms and course are associated with early relapse in opioid-dependent individuals treated with extended-release naltrexone but not buprenorphine-naloxone

Citation: Hammond, C.J., Park, G., Kady, A., Pollack, A., Wenzel, K., & Fishman, M. (2019, July). Depressive symptoms and course are associated with early relapse in opioid-dependent individuals treated with extended-release naltrexone but not buprenorphine-naloxone [Poster presentation]. Presented at Johns Hopkins Department of Psychiatry and Behavioral Sciences Annual Research Potpourri, Baltimore, MD.